136 related articles for article (PubMed ID: 33387887)
1. Novel tankyrase inhibitors suppress TDP-43 aggregate formation.
Tanji K; Mori F; Shirai F; Fukami T; Seimiya H; Utsumi J; Kakita A; Wakabayashi K
Biochem Biophys Res Commun; 2021 Jan; 537():85-92. PubMed ID: 33387887
[TBL] [Abstract][Full Text] [Related]
2. Poly(ADP-Ribose) Prevents Pathological Phase Separation of TDP-43 by Promoting Liquid Demixing and Stress Granule Localization.
McGurk L; Gomes E; Guo L; Mojsilovic-Petrovic J; Tran V; Kalb RG; Shorter J; Bonini NM
Mol Cell; 2018 Sep; 71(5):703-717.e9. PubMed ID: 30100264
[TBL] [Abstract][Full Text] [Related]
3. Nuclear poly(ADP-ribose) activity is a therapeutic target in amyotrophic lateral sclerosis.
McGurk L; Mojsilovic-Petrovic J; Van Deerlin VM; Shorter J; Kalb RG; Lee VM; Trojanowski JQ; Lee EB; Bonini NM
Acta Neuropathol Commun; 2018 Aug; 6(1):84. PubMed ID: 30157956
[TBL] [Abstract][Full Text] [Related]
4. TDP-43, a protein central to amyotrophic lateral sclerosis, is destabilized by tankyrase-1 and -2.
McGurk L; Rifai OM; Bonini NM
J Cell Sci; 2020 Jun; 133(12):. PubMed ID: 32409565
[TBL] [Abstract][Full Text] [Related]
5. Praja1 RING-finger E3 ubiquitin ligase suppresses neuronal cytoplasmic TDP-43 aggregate formation.
Watabe K; Kato Y; Sakuma M; Murata M; Niida-Kawaguchi M; Takemura T; Hanagata N; Tada M; Kakita A; Shibata N
Neuropathology; 2020 Dec; 40(6):570-586. PubMed ID: 32686212
[TBL] [Abstract][Full Text] [Related]
6. Inositol Hexakisphosphate Kinase 2 Promotes Cell Death in Cells with Cytoplasmic TDP-43 Aggregation.
Nagata E; Nonaka T; Moriya Y; Fujii N; Okada Y; Tsukamoto H; Itoh J; Okada C; Satoh T; Arai T; Hasegawa M; Takizawa S
Mol Neurobiol; 2016 Oct; 53(8):5377-83. PubMed ID: 26440668
[TBL] [Abstract][Full Text] [Related]
7. A novel Drosophila model of TDP-43 proteinopathies: N-terminal sequences combined with the Q/N domain induce protein functional loss and locomotion defects.
Langellotti S; Romano V; Romano G; Klima R; Feiguin F; Cragnaz L; Romano M; Baralle FE
Dis Model Mech; 2016 Jun; 9(6):659-69. PubMed ID: 27101846
[TBL] [Abstract][Full Text] [Related]
8. Perry Syndrome: A Distinctive Type of TDP-43 Proteinopathy.
Mishima T; Koga S; Lin WL; Kasanuki K; Castanedes-Casey M; Wszolek ZK; Oh SJ; Tsuboi Y; Dickson DW
J Neuropathol Exp Neurol; 2017 Aug; 76(8):676-682. PubMed ID: 28789478
[TBL] [Abstract][Full Text] [Related]
9. [The molecular mechanisms of intracellular TDP-43 aggregates].
Nonaka T; Arai T; Hasegawa M
Brain Nerve; 2009 Nov; 61(11):1292-300. PubMed ID: 19938686
[TBL] [Abstract][Full Text] [Related]
10. Poly(ADP-ribose) Engages the TDP-43 Nuclear-Localization Sequence to Regulate Granulo-Filamentous Aggregation.
McGurk L; Gomes E; Guo L; Shorter J; Bonini NM
Biochemistry; 2018 Dec; 57(51):6923-6926. PubMed ID: 30540446
[TBL] [Abstract][Full Text] [Related]
11. Metabolism and mis-metabolism of the neuropathological signature protein TDP-43.
Huang CC; Bose JK; Majumder P; Lee KH; Huang JT; Huang JK; Shen CK
J Cell Sci; 2014 Jul; 127(Pt 14):3024-38. PubMed ID: 24860144
[TBL] [Abstract][Full Text] [Related]
12. Tankyrase-1 overexpression reduces genotoxin-induced cell death by inhibiting PARP1.
Yeh TY; Sbodio JI; Nguyen MT; Meyer TN; Lee RM; Chi NW
Mol Cell Biochem; 2005 Aug; 276(1-2):183-92. PubMed ID: 16132700
[TBL] [Abstract][Full Text] [Related]
13. Full-length TDP-43 forms toxic amyloid oligomers that are present in frontotemporal lobar dementia-TDP patients.
Fang YS; Tsai KJ; Chang YJ; Kao P; Woods R; Kuo PH; Wu CC; Liao JY; Chou SC; Lin V; Jin LW; Yuan HS; Cheng IH; Tu PH; Chen YR
Nat Commun; 2014 Sep; 5():4824. PubMed ID: 25215604
[TBL] [Abstract][Full Text] [Related]
14. [Neuropathology of TDP-43 proteinopathy].
Akiyama H; Hasegawa M
Brain Nerve; 2013 Dec; 65(12):1477-89. PubMed ID: 24323933
[TBL] [Abstract][Full Text] [Related]
15. Quantification of the Relative Contributions of Loss-of-function and Gain-of-function Mechanisms in TAR DNA-binding Protein 43 (TDP-43) Proteinopathies.
Cascella R; Capitini C; Fani G; Dobson CM; Cecchi C; Chiti F
J Biol Chem; 2016 Sep; 291(37):19437-48. PubMed ID: 27445339
[TBL] [Abstract][Full Text] [Related]
16. Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis.
Tan RH; Yang Y; Kim WS; Dobson-Stone C; Kwok JB; Kiernan MC; Halliday GM
Acta Neuropathol Commun; 2017 Oct; 5(1):76. PubMed ID: 29078806
[TBL] [Abstract][Full Text] [Related]
17. Low molecular weight species of TDP-43 generated by abnormal splicing form inclusions in amyotrophic lateral sclerosis and result in motor neuron death.
Xiao S; Sanelli T; Chiang H; Sun Y; Chakrabartty A; Keith J; Rogaeva E; Zinman L; Robertson J
Acta Neuropathol; 2015 Jul; 130(1):49-61. PubMed ID: 25788357
[TBL] [Abstract][Full Text] [Related]
18. Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation.
Winton MJ; Igaz LM; Wong MM; Kwong LK; Trojanowski JQ; Lee VM
J Biol Chem; 2008 May; 283(19):13302-9. PubMed ID: 18305110
[TBL] [Abstract][Full Text] [Related]
19. [FTLD/ALS as TDP-43 proteinopathies].
Ishihara T; Ariizumi Y; Shiga A; Yokoseki A; Sato T; Toyoshima Y; Kakita A; Takahashi H; Nishizawa M; Onodera O
Rinsho Shinkeigaku; 2010 Nov; 50(11):1022-4. PubMed ID: 21921552
[TBL] [Abstract][Full Text] [Related]
20. [A new dementia group caused by TDP-43 abnormality].
Arai T; Hosokawa M; Hasegawa M; Akiyama H; Asada T
Seishin Shinkeigaku Zasshi; 2011; 113(6):574-83. PubMed ID: 21815469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
